Shionogi & Co., Ltd. (FRA:SH0)

Germany flag Germany · Delayed Price · Currency is EUR
16.60
+0.70 (4.40%)
Last updated: Jan 30, 2026, 8:03 AM CET
22.06%
Market Cap14.73B +28.5%
Revenue (ttm)2.53B +1.9%
Net Income1.06B +15.5%
EPS1.24 +15.7%
Shares Outn/a
PE Ratio13.92
Forward PEn/a
Dividend0.39 (2.36%)
Ex-Dividend DateSep 29, 2025
Volumen/a
Average Volume15
Open16.60
Previous Close15.90
Day's Range16.60 - 16.60
52-Week Range12.60 - 16.60
Betan/a
RSI65.06
Earnings DateJan 30, 2026

About Shionogi &

Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally. The company was formerly known as Shionogi Shoten Co., Ltd. and changed its name to Shionogi & Co., Ltd. in 1943. The company was founded in 1878 and is headquartered in Osaka, Japan. [Read more]

Industry Pharmaceutical Preparations
Founded 1878
Employees 4,955
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol SH0
Full Company Profile

Financial Performance

In fiscal year 2025, Shionogi &'s revenue was 438.27 billion, an increase of 0.73% compared to the previous year's 435.08 billion. Earnings were 170.44 billion, an increase of 5.19%.

Financial numbers in JPY Financial Statements